Ashish Pershad, M.D., chief of interventional cardiology, Banner University Medical Center, Phoenix,...
Heart Valve Technology
This channel includes news and new device innovations about heart valve technologies, including the aortic valve, mitral valve, pulmonic valve, and tricuspid valve. This includes information on transcatheter valve technologies like transcatheter aortic valve replacement (TAVR, or implantation TAVI), transcatheter mitral valve replacement (TMVR), transcatheter and surgical valve repairs, ad surgical replacement valves.
-
-
Vivian Ng, M.D., assistant professor of medicine and an interventional cardiologist at the NewYork-...
-
Torsten Vahl, M.D., director of experimental and translational research, Structural...
-
Chandan Devireddy, M.D., offers insights about what he saw as the top take aways from...
Videos | Vascular Closure Devices | October 17, 2019
Videos | Heart Valve Technology | October 09, 2019
Videos | TCT | October 04, 2019
A Sapien 3 TAVR valve in position as seen under GE Assist guidance on angiography.
News | Heart Valve Technology | October 04, 2019
October 4, 2019 – A new analysis of the PARTNER 3 Trial data found a modest, but significant, improvement in one-...
The COAPT Economic Analysis sub-study found it is cost effective to treat heart failure patients who have severe secondary mitral regurgitation with MitraClip to reduce their MR symptoms.
News | Heart Failure | October 04, 2019
October 4, 2019 – Results of a new economic analysis of the COAPT Trial data found that transcatheter mitral valve...
News | Heart Valve Technology | October 03, 2019
October 3, 2019 – Five-year results from the PARTNER 2A Trial found patients with severe aortic stenosis (AS) and...
COAPT Trial three-year data show the MitraClip continues to show safety and effectiveness in heart failure patients with secondary mitral reguritation.
News | Heart Failure | October 03, 2019
October 3, 2019 – The three-year results from the...
News | Heart Valve Technology | October 02, 2019
October 2, 2019 – The first randomized trial to compare the safety and efficacy of the new Boston Scientific Acurate...
News | Heart Valve Technology | October 02, 2019
October 2, 2019 – The Abbott Portico FDA investigational device exemption (IDE) study found that 30-day safety and...
Khaldoon Alaswad, M.D., right, director, cardiac catheterization lab, during a complex CTO procedure at Henry Ford Hospital.
Feature | Henry Ford Hospital | October 01, 2019 | Dave Fornell, Editor
Henry Ford Hospital thought leaders...
Videos | Cardiovascular Business | September 30, 2019
A discussion with Ruth Fisher, MBA, vice president of the...
